ArticlesBioPharmaRegulatory August 16, 2016 Design and Qualification of Single-Use Systems Single-use technologies (SUT) have made significant inroads in biopharmaceutical and vaccine... admin-element
ArticlesDownstreamRegulatoryUpstream May 25, 2016 An Integrated Approach to Ensure the Viral Safety of Biotherapeutics Use of continuous cell lines in the manufacture of biological therapeutic products, such as... admin-element
ArticlesRegulatory May 12, 2016 A Platform Approach for the Identity Testing of Multi-Component Cell-Culture Media Cell-culture media are essential raw materials that are required for the manufacture of... admin-element
ArticlesBioPharma April 28, 2016 Platform Approach Speeds Process Development Commercial production of complex biopharmaceuticals such as recombinant monoclonal... admin-element
ArticlesDownstreamRegulatoryUpstream April 14, 2016 Continuous Processing for the Production of Biopharmaceuticals The biosimilars landscape is growing as market factors, such as pricing pressure, advanced... admin-element
Articles March 30, 2016 A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications The Chinese hamster ovary (CHO) cell lines used for the production of recombinant therapeutic proteins... admin-element
ArticlesDownstreamRegulatoryUpstream March 16, 2016 Adherent Cell Culture in Biopharmaceutical Applications: The Cell-Detachment Challenge The necessity to detach cells from a culture substrate during cell harvesting remains one of… admin-element
ArticlesBioPharmaUpstream February 18, 2016 Antibody Production in Microbial Hosts The biopharmaceutical industry is growing exponentially, driven by an ever-increasing demand for monoclonal antibodies (mAbs)… admin-element
ArticlesBioPharmaDownstreamUpstream January 21, 2016 Going Small to Achieve Success on the Commercial Scale Biopharmaceutical manufacturing involves a series of complex unit operations linked together to... admin-element
ArticlesBioPharmaDownstreamRegulatoryUpstream November 19, 2015 Selecting the Right Viral Clearance Technology The introduction of adventitious viral agents is a recognized, inherent risk of biologic drug... admin-element